Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma, Cutaneous Malignant × nintedanib × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma, Cutaneous Malignant 1

Interventions

pembrolizumab 2 nintedanib 1 dabrafenib 1 Vitamin D 1 Surveys and Questionnaires 1 Paclitaxel 1 Eye Movement Desensitization Reprocessing 1 Electrochemotherapy 1 Cholecalciferol 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02308553 2020-10-14

NIPAWILMA

University Hospital, Essen

Phase 1/2 Completed

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡